Nvidia’s stock has skyrocketed 50% in two months, bouncing back from early-year woes with strong AI demand and record ...

Jim Cramer isn’t joining the panic parade over Broadcom’s post-earnings stock dip. He believes the drop was more about the ...

Microsoft’s stock is on an eight-day hot streak, dancing to the rhythm of the AI boom and a powerful partnership with OpenAI.

Alphabet just put on a clinic in stock market swagger, closing at $176.06 after a 1.37% daily gain, outperforming the S&P 500 ...

Mastercard’s stock took a minor -0.71% dip to $585.93, but this tiny slide doesn’t dent its rocket-fueled growth streak. The ...

Constitution Capital increased its stake in Home Depot by 3% in Q1, now holding nearly 24,000 shares valued at $8.68 million.

Generali Investments just poured extra octane into its portfolio by boosting its Exxon Mobil stake 44.5%. The firm bought ...

First Citizens Bank & Trust Co. slightly reduced its JPMorgan Chase holdings by 3.8% during the first quarter. The bank now ...

UBS is holding firm on its Buy rating and $1,050 price target for Eli Lilly, driven by faith in the upcoming SURPASS-CVOT ...

Southern Copper saw a dramatic cut in ownership from Hennion & Walsh, who sold 67.1% of their shares this past quarter.

AbbVie got a shiny new price target of $204 from Bank of America, yet analysts aren’t exactly throwing a party. Eight ...

A securities fraud lawsuit targets UnitedHealth Group over allegedly deceptive statements regarding earnings projections.